Life-extending benefits of liver cancer drug Sorafenib not realistic for many patients
For advanced liver cancer, there's a single approved drug shown to offer patients a chance at longer life. But a new study from the University of North Carolina Lineberger Comprehensive Cancer Center shows that this drug ...
May 18, 2016